CIK 0001674632 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Beta Bionics, Inc.
Sign in to watch- Ticker
- BBNX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475386878
- Phone
- 949-427-7785
- Business address
- 11 HUGHES, IRVINE, CA, 92618
- Former names
- Beta Bionics, Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,285,734
- in 20 filings, $2.5M under 10b5-1 plans
Net −$3,285,734. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-04 | Hopman Mark Chief Commercial Officer | Sale 10b5-1 | −275 | $12.31 | $3K | 130,612 |
| 2026-06-04 | Jones Christy Director | Sale 10b5-1 | −2,811 | $14.00 | $39K | 27,400 |
| 2026-06-02 | Russell Steven Jon Chief Medical Officer | Sale | −4,222 | $12.61 | $53K | 173,849 |
| 2026-06-02 | Saint Sean President & CEO | Sale | −16,872 | $12.61 | $213K | 420,937 |
| 2026-06-02 | Feider Stephen Chief Financial Officer | Sale | −6,676 | $12.61 | $84K | 166,053 |
| 2026-06-02 | Mensinger Mike Chief Product Officer | Sale | −4,378 | $12.61 | $55K | 184,415 |
| 2026-06-02 | Hopman Mark Chief Commercial Officer | Sale | −5,329 | $12.61 | $67K | 130,887 |
| 2026-05-22 | Lezack Adam Director | Sale 10b5-1 | −998 | $11.21 | $11K | 27,399 |
| 2026-05-21 | Jones Christy Director | Sale 10b5-1 | −1,998 | $9.95 | $20K | 13,246 |
| 2026-05-21 | Jones Christy Director | Grant or award 10b5-1 | +16,965 | 30,211 | ||
| 2026-05-21 | Lezack Adam Director | Sale 10b5-1 | −1,000 | $9.95 | $10K | 11,432 |
| 2026-05-21 | Lezack Adam Director | Grant or award 10b5-1 | +16,965 | 28,397 | ||
| 2026-05-21 | Palasis Maria Director | Grant or award | +16,965 | 29,397 | ||
| 2026-05-21 | Dearen Danny L. Director | Grant or award | +16,965 | 32,209 | ||
| 2026-05-21 | CARNEY SEAN Director | Grant or award | +16,965 | 32,209 | ||
| 2026-05-21 | MICHEL GERARD J Director | Grant or award | +16,965 | 33,509 | ||
| 2026-03-04 | Hopman Mark Chief Commercial Officer | Sale 10b5-1 | −353 | $11.57 | $4K | 139,133 |
| 2026-03-02 | Russell Steven Jon Chief Medical Officer | Sale | −1,026 | $12.36 | $13K | 179,096 |
| 2026-03-02 | Saint Sean President & CEO | Sale | −3,384 | $12.36 | $42K | 437,809 |
| 2026-03-02 | Feider Stephen Chief Financial Officer | Sale | −1,428 | $12.36 | $18K | 172,729 |
Page 3 of 11 · 210 trades